An IP-10 (CXCL10)-Derived Peptide Inhibits Angiogenesis

• Cecelia C. Yates-Binder ,

  * E-mail: cey4@pitt.edu (CCYB); Rjb8@pitt.edu (RJB)

  Affiliations Tuskegee University, Center for Cancer Research, Tuskegee, Alabama, United States of America, Departments of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, United States of America, Veterans Affairs Pittsburgh Healthcare System, Pittsburgh, Pennsylvania, United States of America

  ⨯
• Margaret Rodgers,

  Affiliation Veterans Affairs Pittsburgh Healthcare System, Pittsburgh, Pennsylvania, United States of America

  ⨯
• Jesse Jaynes,

  Affiliation Tuskegee University, Center for Cancer Research, Tuskegee, Alabama, United States of America

  ⨯
• Alan Wells,

  Affiliations Tuskegee University, Center for Cancer Research, Tuskegee, Alabama, United States of America, Departments of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, United States of America, Veterans Affairs Pittsburgh Healthcare System, Pittsburgh, Pennsylvania, United States of America

  ⨯
• Richard J. Bodnar ,

  * E-mail: cey4@pitt.edu (CCYB); Rjb8@pitt.edu (RJB)

  Affiliations Departments of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, United States of America, Veterans Affairs Pittsburgh Healthcare System, Pittsburgh, Pennsylvania, United States of America

  ⨯
• Timothy Turner

  Affiliation Tuskegee University, Center for Cancer Research, Tuskegee, Alabama, United States of America

  ⨯